CIK 0001035354 · Non-accelerated filer<br>Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841368850
- Phone
- 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement
- 8-K Event Regulation FD disclosure
- 10KSB Other 10KSB
- 3 Insider Initial Statement of Ownership
- 10QSB Other 10QSB
- 424B3 Offering Prospectus
- S-3 Offering Registration Statement
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- SC 13G Stake Amended Statement of Ownership
- 10QSB Other 10QSB
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Item 5
- REGDEX Other REGDEX
- 8-K Event Item 5 · Item 7
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Insider Changes in Ownership
Page 63 of 68 · 1,360 filings